Cargando…
Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity
Autoimmune manifestations were reported in people infected with SARS-CoV-2. Repetitive exposure of mice to foreign antigen may lead to the onset of autoimmunity. We therefore investigated whether repetitive exposure to the SARS-CoV-2 spike protein could result in autoimmunity. To address this hypoth...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931423/ https://www.ncbi.nlm.nih.gov/pubmed/36804225 http://dx.doi.org/10.1016/j.clim.2023.109264 |
_version_ | 1784889247280398336 |
---|---|
author | Scherlinger, Marc Sibilia, Jean Tsokos, George C. Gottenberg, Jacques-Eric |
author_facet | Scherlinger, Marc Sibilia, Jean Tsokos, George C. Gottenberg, Jacques-Eric |
author_sort | Scherlinger, Marc |
collection | PubMed |
description | Autoimmune manifestations were reported in people infected with SARS-CoV-2. Repetitive exposure of mice to foreign antigen may lead to the onset of autoimmunity. We therefore investigated whether repetitive exposure to the SARS-CoV-2 spike protein could result in autoimmunity. To address this hypothesis, we repeatedly immunized C57Bl/6 mice with spike protein injected intraperitoneally. At the end of the immunization, mice which received spike protein produced anti-spike IgG but none of them developed anti-dsDNA antibodies or proteinuria. In conclusion, repetitive immunization with SARS-CoV-2 spike protein does not induce autoimmunity in the present mice model. Albeit reassuring, these results need to be confirmed by large epidemiological study evaluating the incidence of autoimmune diseases in individuals with repetitive SARS-CoV-2 antigen exposure. |
format | Online Article Text |
id | pubmed-9931423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99314232023-02-16 Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity Scherlinger, Marc Sibilia, Jean Tsokos, George C. Gottenberg, Jacques-Eric Clin Immunol Letter to the Editor Autoimmune manifestations were reported in people infected with SARS-CoV-2. Repetitive exposure of mice to foreign antigen may lead to the onset of autoimmunity. We therefore investigated whether repetitive exposure to the SARS-CoV-2 spike protein could result in autoimmunity. To address this hypothesis, we repeatedly immunized C57Bl/6 mice with spike protein injected intraperitoneally. At the end of the immunization, mice which received spike protein produced anti-spike IgG but none of them developed anti-dsDNA antibodies or proteinuria. In conclusion, repetitive immunization with SARS-CoV-2 spike protein does not induce autoimmunity in the present mice model. Albeit reassuring, these results need to be confirmed by large epidemiological study evaluating the incidence of autoimmune diseases in individuals with repetitive SARS-CoV-2 antigen exposure. Elsevier Inc. 2023-03 2023-02-16 /pmc/articles/PMC9931423/ /pubmed/36804225 http://dx.doi.org/10.1016/j.clim.2023.109264 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Scherlinger, Marc Sibilia, Jean Tsokos, George C. Gottenberg, Jacques-Eric Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity |
title | Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity |
title_full | Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity |
title_fullStr | Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity |
title_full_unstemmed | Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity |
title_short | Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity |
title_sort | chronic stimulation with sars-cov-2 spike protein does not trigger autoimmunity |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931423/ https://www.ncbi.nlm.nih.gov/pubmed/36804225 http://dx.doi.org/10.1016/j.clim.2023.109264 |
work_keys_str_mv | AT scherlingermarc chronicstimulationwithsarscov2spikeproteindoesnottriggerautoimmunity AT sibiliajean chronicstimulationwithsarscov2spikeproteindoesnottriggerautoimmunity AT tsokosgeorgec chronicstimulationwithsarscov2spikeproteindoesnottriggerautoimmunity AT gottenbergjacqueseric chronicstimulationwithsarscov2spikeproteindoesnottriggerautoimmunity |